Related Experiment Videos
Ex-vivo results using a new pullback atherectomy catheter (PAC).
T A Fischell1, R E Fischell, R I White
1Cardiology Division, Stanford University Medical Center, CA 94305.
Catheterization and Cardiovascular Diagnosis
|December 1, 1990
Summary
This study explored a new retrograde atherectomy catheter for removing dangerous plaque buildup in leg arteries. Preclinical tests show this Pullback atherectomy catheter is a feasible method for definitive plaque removal.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Biomedical Engineering
Background:
- Atheromatous plaque buildup in superficial femoral arteries causes significant disease.
- Current atherectomy methods face challenges in effectively removing extensive plaque.
- Novel devices are needed to improve treatment outcomes for peripheral artery disease.
Purpose of the Study:
- To assess the feasibility of a novel retrograde cutting atherectomy catheter for definitive atheromatous plaque removal.
- To evaluate the efficacy of the Pullback Atherectomy Catheter in severely diseased cadaveric superficial femoral arteries.
Main Methods:
- Retrograde atherectomy using sequentially larger Pullback Atherectomy Catheters (2.5 mm, 3.0 mm, 3.5 mm) was performed on 13 cadaveric superficial femoral arteries.
- Experiments utilized either mounted tissue (n=10) or in situ specimens (n=3).
- Outcomes were assessed via angiography and light microscopy.
Main Results:
- The procedure was tested on arteries with an average pre-atherectomy stenosis of 95%.
- Post-atherectomy, the mean stenosis was reduced to 21%.
- One instance of vessel perforation occurred during the 13 experiments.
Conclusions:
- Retrograde atherectomy using the Pullback Atherectomy Catheter demonstrates feasibility for definitive plaque removal in preclinical settings.
- Further research is required to determine the clinical utility of this novel retrograde atherectomy device.
- This study provides a foundation for future investigations into retrograde atherectomy for peripheral artery disease treatment.